|

Liver Cancer Clinical Trials in Michigan

29 recruiting studies across 21 cities

All Trials in Michigan

Phase
Trial Phase Location
A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaPhase 2Ann Arbor
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaPhase 1/2Ann Arbor
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular CarcinomaPhase 1Ann Arbor
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver CancerPhase 2Ann Arbor
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver NodulesN/AAnn Arbor
National Liver Cancer Screening TrialPhase 4Ann Arbor
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIN/AAnn Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—Ann Arbor
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver MetastasesPhase 2Ann Arbor
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPhase 1/2Ann Arbor
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialPhase 3Ann Arbor
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsPhase 2Ann Arbor
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT TrialPhase 3Brownstown
The Vanguard Study: Testing a New Way to Screen for CancerN/ABrownstown
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsPhase 1/2Dearborn
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsPhase 1/2Detroit
A Study of Methylprednisolone in People Having Liver SurgeryPhase 3Detroit
A Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsPhase 1Detroit
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)Phase 1/2Detroit
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaPhase 3Detroit
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT—Detroit
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)—Detroit
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway AberrationsPhase 1Detroit
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsPhase 1/2Detroit
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsPhase 1Detroit
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsPhase 1Grand Rapids
A Study of MGC026 in Participants With Advanced Solid TumorsPhase 1Grand Rapids
A Study of ZW251 in Participants With Advanced Solid TumorsPhase 1Grand Rapids
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400Phase 1Grand Rapids

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.